Literature DB >> 46892

Complement-induced histamine release from human basophils. I. Generation of activity in human serum.

W A Hook, R P Siraganian, S M Wahl.   

Abstract

The incubation of zymosan, endotoxin, or immune aggregates with normal human serum activates a factor which induces release of histamine from autologous basophils. The reaction can be divided into two steps: in the first, complement must be activated and in the second, the histamine-releasing factor interacts with basophils. The generation of histamine-releasing activity in serum occurs at 17 to 37 degrees C but not at 0 degrees C, is inhibited by heating the serum at 56 degrees C for 30 min, or by the addition of EDTA to the serum. Once generated, the histamine-liberating activity is stable to heating at 56 degrees C for 30 min. Gel filtration of the activated serum demonstrated that this factor eluted in the same region as a factor with chemotactic activity. Both factors have a molecular weight of about 16,000 daltons and their activities were inhibited by antibody to human C5. This is therefore a pathway for histamine release by C5a where the activation of the basophil is unrelated to the membrane bound IgE.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Acute inhalation toxicity of cotton plant dusts.

Authors:  R Rylander; M C Snella
Journal:  Br J Ind Med       Date:  1976-08

3.  The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.

Authors:  H Jürgensen; H Behrendt; B Damerau; W Schmutzler
Journal:  Agents Actions       Date:  1986-04

4.  Rat mast cell activation and inactivation: differences when various ligands are used to induce secretion.

Authors:  R M Healicon; J C Foreman
Journal:  Agents Actions       Date:  1985-04

5.  Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.

Authors:  M Kings; U E Nydegger; A L de Weck
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

6.  Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response.

Authors:  A D Mease; D P Burgess; P J Thomas
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

7.  Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.

Authors:  M M Glovsky; T E Hugli; T Ishizaka; L M Lichtenstein; B W Erickson
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

8.  The mechanism of basophil histamine release in patients with periodontal disease.

Authors:  A Olsson-Wennström; J L Wennström; S E Mergenhagen; R P Siraganian
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

9.  Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation.

Authors:  D A Bass; T A Gonwa; P Szejda; M S Cousart; L R DeChatelet; C E McCall
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

Review 10.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.